Estrogen metabolizing enzymes in endometrium and endometriosis
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Estradiol (E(2)) is an important promoter of the growth of both eutopic and ectopic endometrium. The findings with regard to the expression and activity of steroidogenic enzymes in endometrium of controls, in endometrium of endometriosis patients and in endometriotic lesions are not consistent. METHODS: In this study, we have looked at the mRNA expression and protein levels of a range of steroidogenic enzymes [aromatase, 17beta-hydroxysteroid dehydrogenases (17beta-HSD) type 1, 2 and 4, estrogen sulfotransferase (EST) and steroid sulfatase (STS)] in eutopic and ectopic endometrium of patients (n = 14) with deep-infiltrative endometriosis as well as in disease-free endometrium (n = 48) using real-time PCR and immunocytochemistry. In addition, we evaluated their menstrual cycle-related expression patterns, and investigated their steroid responsiveness in explant cultures. RESULTS: Aromatase and 17beta-HSD type 1 mRNA levels were extremely low in normal human endometrium, while mRNAs for types 2 and 4 17beta-HSD, EST and STS were readily detectable. Only 17beta-HSD type 2 and EST genes showed sensitivity to progesterone in normal endometrium. Types 1 and 2 17beta-HSD and STS protein was detected in normal endometrium using new polyclonal antibodies. CONCLUSIONS: In endometriosis lesions, the balance is tilted in favor of enzymes producing E(2). This is due to a suppression of types 2 and 4 17beta-HSD, and an increased expression of aromatase and type 1 17beta-HSD in ectopic endometrium.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STS is expressed in normal endometrial tissues and in endometrial cancers [51,52].”
From Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders (2018) · cites this paper as [51]
In the citing paper
“At the protein level, there was no evidence of HSD17B1 hyperexpression in endometriosis tissue ( 41 , 45 ).”
From Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism (2022) · cites this paper as [41]
In the citing paper
“This result diverges from HSD17B1 mRNA level, which was higher than in controls, raising the hypothesis that the expression of the HSD17B1 gene may therefore not necessarily reflect changes at the functional protein level ( 41 ).”
From Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism (2022) · cites this paper as [41]
In the citing paper
“Conflicting findings have been published by from Dassen et al., that, evaluated 14 women with rectovaginal endometriosis and did not observe any differences between STS mRNA levels of endometriosis and healthy tissues (P, 0.05) ( 41 ).”
From Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism (2022) · cites this paper as [41]
In the citing paper
“Interestingly, two studies reported a higher expression of SULT1E1 in endometriotic lesions than in normal endometrium: rectovaginal endometriosis lesions ( 41 ) and superficial peritoneal lesions ( 56 ) showed higher expression of EST compared to the control and had a positive correlation with STS expression.”
From Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism (2022) · cites this paper as [41]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“The fold-change in expression was calculated using the DD Ct method, with cyclophylin A mRNA as an internal control (Livak and Schmittgen, 2001).”
MethodAromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537 · cited 1×
“The type 1 17b-HSD is still considered a ratelimiting enzyme in the production of E 2 , since the major product of the aromatase activity in humans is estrone and not E 2 (Simpson et al., 1994), and is therefore still an interesting alternative target for therapy.”
BackgroundNoyes, R. W., Hertig, A. T., & Rock, J. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33500-1 · Cited by 941
Aromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 4×
“Aromatase overexpression has now indeed been confirmed in numerous reports at the transcript level (Noble et al., 1996; Bulun et al., 1997; Matsuzaki et al., 2006; Smuc et al., 2007), at the protein level (Kitawaki et al., 1997,1999; Murakami et al., 2006; Velasco et al., 2006), as well as at the…”
BackgroundResultInfluentialMinireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324 · cited 1×
“In addition, P450 enzymes like aromatase also need NADPH and molecular oxygen and will irreversibly oxidize the steroid nucleus (Miller, 2005).”
BackgroundZeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Moghrabi, N., Andersson, S., Johns, A., Meng, L., Putman, M., Carr, B., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5301 · Cited by 308 · cited 4×
“Endometriosis is an estrogen-dependent disease (Dizerega et al., 1980; Zeitoun et al., 1998).”
BackgroundResultInfluentialKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305 · cited 4×
“…numerous reports at the transcript level (Noble et al., 1996; Bulun et al., 1997; Matsuzaki et al., 2006; Smuc et al., 2007), at the protein level (Kitawaki et al., 1997,1999; Murakami et al., 2006; Velasco et al., 2006), as well as at the activity level (Kitawaki et al., 1997; Noble et al.,…”
BackgroundInfluentialInduction of Human Endometrial Estradiol Dehydrogenase by Progestins
TSENG, L., & GURPIDE, E. (1975) · Endocrinology · doi:10.1210/endo-97-4-825 · Cited by 301 · cited 2×
“There is clear evidence that transcription of the 17HSD2 gene in normal endometrium is regulated by progesterone (Tseng and Gurpide, 1975; Kauppila, 1984; Casey et al., 1994; Mustonen et al., 1998; Zhang et al., 2006), even though some inconsistent findings have been reported (Kitawaki et al.,…”
BackgroundProstaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression
Dizerega, G. S., Barber, D. L., & Hodgen, G. D. (1980) · Fertility and Sterility · doi:10.1016/s0015-0282(16)44780-1 · Cited by 282 · cited 1×
“Endometriosis is an estrogen-dependent disease (Dizerega et al., 1980; Zeitoun et al., 1998).”
Cited by
Endometriosis and infertility: pathophysiology and management
de Ziegler, D., Borghese, B., & Chapron, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60490-4 · Cited by 843
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing
Crain, D. A., Janssen, S. J., Edwards, T. M., Heindel, J., Ho, S.-M., Hunt, P., Iguchi, T., Juul, A., McLachlan, J. A., Schwartz, J., et al. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.067 · Cited by 465
The Regulation of Steroid Action by Sulfation and Desulfation
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419
Pathogenetic Mechanisms of Deep Infiltrating Endometriosis
Tosti, C., Pinzauti, S., Santulli, P., Chapron, C., & Petraglia, F. (2015) · Reproductive Sciences · doi:10.1177/1933719115592713 · Cited by 222
Huhtinen, K., Desai, R., Ståhle, M., Salminen, A., Handelsman, D. J., Perheentupa, A., & Poutanen, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1154 · Cited by 195
Kirwan, J. A., Brennan, L., Broadhurst, D., Fiehn, O., Cascante, M., Dunn, W. B., Schmidt, M. A., & Velagapudi, V. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287045 · Cited by 170
Oestrogen and progesterone regulation of inflammatory processes in the human endometrium
King, A. E., & Critchley, H. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.003 · Cited by 169
Aghajanova, L., Hamilton, A., Kwintkiewicz, J., Vo, K. C., & Giudice, L. C. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.070300 · Cited by 168
“HSD17B2 has been reported by others in both epithelium and stroma with high expression in the former [69, 70].”
Estrogen metabolism and action in endometriosis
Rižner, T. L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.022 · Cited by 153
Treatment of pain associated with deep endometriosis: alternatives and evidence
Ferrero, S., Alessandri, F., Racca, A., & Maggiore, U. L. R. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.08.031 · Cited by 147
“Estrogen (E) biosynthesis is upregulated because of the increased expression of aromatase P450 (responsible for the conversion of androgens to E2) (5) and of 17b-hydrosteroid dehydrogenase type 1 (responsible for the conversion of estrone [E1] to E2) (6).”
BackgroundUterine disorders and pregnancy complications: insights from mouse models
Lim, H. J., & Wang, H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41210 · Cited by 139
Day, J. M., Tutill, H. J., Purohit, A., & Reed, M. J. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0042 · Cited by 122
“A recent study, however, indicated that there is a down-regulation of 17b-HSD2 mRNA expression in endometriotic samples, while both aromatase and 17b-HSD1 are up-regulated in comparison with normal endometrium (Dassen et al. 2007).”
BackgroundIncreased Production of 17β-Estradiol in Endometriosis Lesions Is the Result of Impaired Metabolism
Delvoux, B., Groothuis, P., D'Hooghe, T., Kyama, C., Dunselman, G., & Romano, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2218 · Cited by 121
“We have previously shown that in endometriotic tissues mRNA levels of type 2 17 -HSD are lower compared with the eutopic endometrium in the same patient (17).”
BackgroundResultInfluentialSelf-citationSaloniemi, T., Jokela, H., Strauss, L., Pakarinen, P., & Poutanen, M. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0315 · Cited by 109
“However, in most of the studies, the HSD17B1 expression is detected in normal endometrium, endometriosis specimens and endometriotic cancer (Mäentausta et al. 1991, 1992, Casey et al. 1994, Zeitoun et al. 1998, Smuc et al. 2006, Dassen et al. 2007, Fechner et al. 2007).”
BackgroundAndrogens and endometrium: new insights and new targets
Simitsidellis, I., Saunders, P. T. K., & Gibson, D. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.022 · Cited by 107
Estrogen biosynthesis and signaling in endometriosis
Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107
Estrogen Sulfotransferases in Breast and Endometrial Cancers
Pasqualini, J. R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04113.x · Cited by 102
Disturbed estrogen and progesterone action in ovarian endometriosis
Šmuc, T., Hevir, N., Ribič-Pucelj, M., Husen, B., Thole, H., & Rižner, T. L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.07.020 · Cited by 101
“In contrast, Matsuzaki et al. (2006) and Dassen et al. (2007) have shown lower expression of 17β-HSD type 2 in deep infiltrating endometriotic tissue.”
BackgroundSelf-citationThe important roles of steroid sulfatase and sulfotransferases in gynecological diseases
Rižner, T. L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00030 · Cited by 98
“…significant differences in STS expression have been reported at the mRNA level between the proliferative and secretory phases (Colette et al., 2013), while at the protein level, significant down-regulation was seen in the late secretory phase, compared to the menstrual phase (Dassen et al., 2007).”
BackgroundResultInfluentialNasu, K., Kawano, Y., Tsukamoto, Y., Takano, M., Takai, N., Li, H., Furukawa, Y., Abe, W., Moriyama, M., & Narahara, H. (2011) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2011.01663.x · Cited by 88
“Previous reports have found that aromatase mRNA levels were significantly higher in the eutopic endometrial cells of patients with endometriosis compared with those from women without endometriosis.(41,94,95) In contrast, aromatase expression is reported to be absent in the eutopic endometrium in women without endomet…”
ResultLocal estrogen formation and its regulation in endometriosis
Mori, T., Ito, F., Koshiba, A., Kataoka, H., Takaoka, O., Okimura, H., Khan, K. N., & Kitawaki, J. (2019) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12285 · Cited by 98
The role of androgens in women's health and wellbeing
Bianchi, V. E., Bresciani, E., Meanti, R., Rizzi, L., Omeljaniuk, R. J., & Torsello, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105758 · Cited by 99
Absence of aromatase protein and mRNA expression in endometriosis
Colette, S., Lousse, J. C., Defrere, S., Curaba, M., Heilier, J. F., Van Langendonckt, A., Mestdagt, M., Foidart, J. M., Loumaye, E., & Donnez, J. (2009) · Human Reproduction · doi:10.1093/humrep/dep199 · Cited by 88
“(Heilier et al., 2006b; Bukulmez et al., 2007; Dassen et al., 2007; Kyama et al., 2007; Smuc et al., 2007; Aghajanova et al., 2009).”
BackgroundMethodSelf-citationCurcumin inhibits endometriosis endometrial cells by reducing estradiol production.
Zhang, Y., Cao, H., Yu, Z. Y., Peng, H.-Y., & Chang-jun, Z. (2013) · Europe PMC (PubMed Central) · Cited by 89
Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis
Tokushige, N., Markham, R., Russell, P., & Fraser, I. S. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.07.1774 · Cited by 80
Panda, H., Chuang, T., Luo, X., & Chegini, N. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1018 · Cited by 79
“More importantly, our observation that CYP19A1 (aromatase) is a direct target of miR-98 further implicates miR-98 regulatory function in the local estrogen biosynthesis, which has been documented in endometrial disorders such as endometriosis and endometrial cancer (13, 41).”
BackgroundPharmacokinetics, metabolism and serum concentrations of progestins used in contraception
Bick, A. J., Toit, R. L.-D., Skosana, S. B., Africander, D., & Hapgood, J. P. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107789 · Cited by 78
Starčević, Š., Brožič, P., Turk, S., Cesar, J., Rižner, T. L., & Gobec, S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101104z · Cited by 76
Konings, G. F. J., Brentjens, L. S., Delvoux, B., Linnanen, T., Cornel, K. M. C., Koskimies, P., Bongers, M. Y., Kruitwagen, R. F. P. M., Xanthoulea, S., & Romano, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00940 · Cited by 74
“Type 2 17βHSD, AKR1C3/17βHSD5 and 3βHSD1 give strong reactivity in the glandular epithelium (Rhee et al., 2003; Ito et al., 2006; Dassen et al., 2007; Vani et al., 2007; Smuc and Rizner, 2009; Zakharov et al., 2010; Colette et al., 2013; Mori et al., 2015; Sinreih et al., 2017a).”
BackgroundSelf-citationIzawa, M., Taniguchi, F., Uegaki, T., Takai, E., Iwabe, T., Terakawa, N., & Harada, T. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.024 · Cited by 73
Khan, M. A., Sengupta, J., Mittal, S., & Ghosh, D. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-84 · Cited by 73
“The pathogenesis of endometriosis has also been associated with excessive production of estrogens by up-regulated expression of aromatase and 17β-HSD type 1, and suppression of 17β-HSD types 2 and 4, collectively resulting in an increased ratio of estradiol-17β to estrone in ectopic tissues [39-42].”
BackgroundEndometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103276 · Cited by 70
“STS is expressed in normal endometrial tissues and in endometrial cancers [51,52].”
BackgroundDelvoux, B., D'Hooghe, T., Kyama, C., Koskimies, P., Hermans, R. J. J., Dunselman, G. A., & Romano, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2851 · Cited by 59
“Low levels of type 2 17 -HSD may also result in excess formation of 17 -estradiol, even in the absence of elevated 17 -HSD type 1 levels (16, 30).”
BackgroundSelf-citationLu, J., Ling, X., Liu, L., Jiang, A., Ren, C., Lü, C., & Yu, Z. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119381 · Cited by 57
Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors
Rauhamäki, S., Postila, P. A., Niinivehmas, S. P., Kortet, S., Schildt, E., Pasanen, M., Manivannan, E., Ahinko, M., Koskimies, P., Nyberg, N., et al. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00041 · Cited by 55
“17-β-hydroxysteroid dehydrogenase 1 (HSD1), which functions as the catalyst of the final reducing step in the estradiol biosynthesis, is often overexpressed in breast cancer and endometriotic tissue (Vihko et al., 2004; Dassen et al., 2007; Hanamura et al., 2014).”
BackgroundSteroid sulphatase and its inhibitors: past, present, and future
Foster, P. A. (2021) · Molecules · doi:10.3390/molecules26102852 · Cited by 49
Dienogest reduces HSD17β1 expression and activity in endometriosis
Mori, T., Ito, F., Matsushima, H., Takaoka, O., Koshiba, A., Tanaka, Y., Kusuki, I., & Kitawaki, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0052 · Cited by 40
Hevir, N., Vouk, K., Šinkovec, J., Ribič-Pucelj, M., & Lanišnik Rižner, T. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.003 · Cited by 48
Steroid sulfatase and estrogen sulfotransferase in human carcinomas
Suzuki, T., Miki, Y., Nakamura, Y., Ito, K., & Sasano, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.001 · Cited by 47
Saloniemi, T., Järvensivu, P., Koskimies, P., Jokela, H., Lamminen, T., Ghaem‐Maghami, S., Dina, R. E., Damdimopoulou, P., Mäkelä, S., Perheentupa, A. H., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090325 · Cited by 46
Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model
Colette, S., Defrere, S., Lousse, J. C., Van Langendonckt, A., Gotteland, J. P., Loumaye, E., & Donnez, J. (2011) · Human Reproduction · doi:10.1093/humrep/der079 · Cited by 45
“On the contrary, STS is known to be widely distributed throughout the body and present in eutopic and ectopic endometrium (Carlström et al., 1988; Yamamoto et al., 1993; Ezaki et al., 2001; Utsunomiya et al., 2004; Dassen et al., 2007).”
BackgroundSelf-citationPiccinato, C. A., Neme, R. M., Torres, N., Sanches, L. R., Derogis, P. B. M. C., Brudniewski, H. F., Rosa e Silva, J. C., & Ferriani, R. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.12.025 · Cited by 45
“control endometria [11, 14], although differential expression was detected between lesions from different sites, such as between ovarian and deep endometriosis [14].”
InfluentialEmerging therapy for endometriosis
Lindsay, S. F., Luciano, D. E., & Luciano, A. A. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1051966 · Cited by 45
“These variations in ligand expression support implantation and proliferation of refluxed endometrium in patients who develop the disease [1,4,9].”
BackgroundHeinosalo, T., Saarinen, N., & POUTANEN, M. H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.08.004 · Cited by 43
Colgrave, E. M., Bittinger, S. E., Healey, M., Dior, U. P., Rogers, P. A. W., Keast, J. R., Girling, J. E., & Holdsworth‐Carson, S. J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa249 · Cited by 44
Differential expression of steroidogenic enzymes according to endometriosis type
Colette, S., Defrère, S., Kerk, O. V., Langendonckt, A. V., Dolmans, M., & Donnez, J. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.08.003 · Cited by 39
Self-citationBlocking oestradiol synthesis pathways with potent and selective coumarin derivatives
Niinivehmas, S. P., Postila, P. A., Rauhamäki, S., Manivannan, E., Kortet, S., Ahinko, M., Huuskonen, P., Nyberg, N., Koskimies, P., Lätti, S., et al. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1452919 · Cited by 38
“3–(3-fluoro-4-hydroxyphenyl)-6-methoxy-2H-chromen-2-one (7).”
Steroid regulation of menstrual bleeding and endometrial repair
Maybin, J. A., & Critchley, H. (2012) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9228-2 · Cited by 37
“17β-hydroxysteroid dehydrogenase (HSD)-2 inactivates oestrogen and testosterone and activates progesterone and has been detected in endometrial epithelial cells [96, 97].”
BackgroundThe Effects and Possible Mechanisms of Puerarin to Treat Endometriosis Model Rats
Yu, J., Zhao, L., Zhang, D., Zhai, D., Shen, W., Bai, L., Liu, Y., Cai, Z., Li, J., & Yu, C. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/269138 · Cited by 33
“[23] reported that 17β hydroxy steroid dehydrogenase 1,2,3,5,7,12 had close relationship with the hormone metabolism, especially 17β-hsd-1 and 17β-hsd-2.”
BackgroundValour, D., Hue, I., Degrelle, S. A., Dejean, S., Marot, G., Dubois, O., Germain, G., Humblot, P., Ponter, A. A. A., Charpigny, G., et al. (2012) · Reproduction in Domestic Animals · doi:10.1111/rda.12113 · Cited by 33
Chronic pelvic pain: Pathogenesis and validated assessment
Yosef, A. H., Ahmed, A. G. M., Al-Hussaini, T. K., Abdellah, M. S., Cua, G., & Bedaiwy, M. A. (2016) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2016.08.001 · Cited by 34
Andrade, S. S., Azevedo, A. D. C., Guerra, I. M., Paredes‐Gamero, E. J., Gonçalves, G., Bonetti, T. C., Albertoni, G., Schor, E., Barreto, J. A., Oliva, M. L. V., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.034 · Cited by 31
Emerging drugs for endometriosis
Guo, S.-W. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802548360 · Cited by 24
“Now the consensus is that in endometriosis lesion, there is an increased local production of estrogen due to a suppression of types 2 and 4 17 β -hydroxysteroid dehydrogenases (17 β -HSDs), and an increased expression of aromatase and type 1 17 β -HSD [22,105] .”
BackgroundLü, X., Wu, Y. R., Gao, X., Wang, Y., Wang, L., & Sun, X. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.055 · Cited by 28
Järvensivu, P., Saloniemi-Heinonen, T., Awosanya, M., Koskimies, P., Saarinen, N., & POUTANEN, M. H. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.01.008 · Cited by 28
Pohl, O., Bestel, E., & Gotteland, J. (2014) · Reproductive Sciences · doi:10.1177/1933719114522526 · Cited by 26
Are aromatase inhibitors effective in endometriosis treatment?
Colette, S., & Donnez, J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.581226 · Cited by 27
“Indeed, from the end of the 1990s until very recently, aromatase was widely believed to be expressed at the transcriptional [20-48], protein [21,23,27,29,33,37,49-55] and activity levels [21,22,26,33,41,56-58].”
BackgroundSelf-citationYin, Q., Fischer, L., Nöthling, C., & Schaefer, W. R. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1047448 · Cited by 24
Postmenopausal endometriosis, where are we now?
Ladanyi, C., Boyd, S., Sticco, P. L., & Mohling, S. I. (2019) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000548 · Cited by 22
“The total quantity of estrogen production is a balance between synthesis and inactivation regulated by aromatase, 17b-hydroxysteroid (HSD17B), and the steroidogenic acute regulatory protein (StAR) [81,82].”
BackgroundLee, S. R., Kim, S. H., Lee, H. W., Kim, Y., Chae, H. D., Kim, C., & Kang, B. M. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00760.x · Cited by 21
Hamidovic, A., Soumare, F., Naveed, A., Davis, J. M., Sun, J., & Dang, N. (2022) · Metabolites · doi:10.3390/metabo12100941 · Cited by 21
“This effect of progesterone in the secretory phase is similar to its effect on the related sulfotransferase SULT1E1, which forms estradiol-sulfate, thereby antagonizing the effect of estradiol in the endometrium [31,35].”
BackgroundMai, H., Wei, Y.-P., Yin, Y., Huang, S., Lin, H., Liao, Y., Liu, X., Chen, X., Shi, H., Liu, C., et al. (2019) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2018.1549290 · Cited by 21
“Hormone therapy can sometimes induce postmenopausal endometriosis (Oxholm et al. 2007), and estrogen is now generally accepted as a major risk factor for endometriosis (Dassen et al. 2007).”
BackgroundInsights from genomic studies on the role of sex steroids in the aetiology of endometriosis
Saunders, P. T. K. (2022) · Reproduction and Fertility · doi:10.1530/raf-21-0078 · Cited by 20
Digestive system deep infiltrating endometriosis: What do we know
Yin, W., Li, X., Liu, P., Li, Y., Liu, J., Yu, S., & Tai, S. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17921 · Cited by 20
Geethadevi, A., Sharma, J. B., Roy, K. K., Sengupta, J., & Ghosh, D. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0553-0 · Cited by 20
“endometriosis (DIE), which is characterized by the suppression of 17β-HSDs 2 and 4 along with increased expression of aromatase and 17β-HSD1 [66].”
BackgroundCuevas, C. A., Tapia-Pizarro, A., Salvatierra, A. M., Munroe, D. J., Velásquez, L., & Croxatto, H. B. (2016) · Reproduction · doi:10.1530/rep-15-0458 · Cited by 19
Mancini, F., Milardi, D., Carfagna, P., Grande, G., Miranda, V., Nardone, A. D. C., Ricciardi, D., Pontecorvi, A., Marana, R., & Nardone, F. D. C. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.12.008 · Cited by 19
Essono, S. M., Mvondo, M. A., Ngadjui, E., Nguimatio, F. X. K., & Watcho, P. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8521831 · Cited by 19
“Moreover, it has been reported that the active estrogen (estradiol (E2)) is a major contributor to developmental angiogenesis of endometriotic tissue [7].”
BackgroundGao, Y., Shen, M., Ma, X., Li, J., Wang, B., Wang, J., & Tian, J. (2019) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.04.004 · Cited by 18
“They are altered in both eutopic and ectopic endometrium (endometriosis) of patients with endometriosis [26].”
BackgroundTamura, K., Yoshie, M., Kusama, K., & Tsuru, A. (2025) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12663 · Cited by 18
“Expression of CYP19A1 and hydroxysteroid dehydrogenase (HSD)17B1, the enzymes that mediate E2 synthesis, is higher in deep-invasive endometriosis than in eutopic and normal endometrium [114].”
Brentjens, L. S., Obukhova, D., den Hartog, J. E., Delvoux, B., Koskivuori, J., Auriola, S. O. K., Häkkinen, M. R., Bui, B. N., van Hoogenhuijze, N. E., Mackens, S., et al. (2023) · F&S Science · doi:10.1016/j.xfss.2023.04.003 · Cited by 18
Self-citationPoirier, D., Nyachieo, A., Romano, A., Roy, J., Maltais, R., Chai, D. C., Delvoux, B., Tomassetti, C., & Vanhie, A. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106136 · Cited by 18
Self-citationAgarwal, D., & Chaudhary, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12123968 · Cited by 18
“The primary source of estradiol is the ovary, and estradiol has been recently found to be an effective regulator of endometriosis [41].”
BackgroundBiochemical and biological evaluation of novel potent coumarin inhibitor of 17β-HSD type 1
Starčević, Š., Kocbek, P., Hribar, G., Rižner, T. L., & Gobec, S. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.002 · Cited by 17
Mercorio, A., Giampaolino, P., Romano, A., Dällenbach, P., & Pluchino, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.950866 · Cited by 16
“Interestingly, two studies reported a higher expression of SULT1E1 in endometriotic lesions than in normal endometrium: rectovaginal endometriosis lesions (41) and superficial peritoneal lesions (56) showed higher expression of EST compared to the control and had a positive correlation with STS expression.”
BackgroundResultInfluentialda Costa, K. D. A., Malvezzi, H., Dobo, C., Neme, R. M., Filippi, R. Z., Aloia, T. P. A., Prado, E. R., Meola, J., & Piccinato, C. D. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.854991 · Cited by 16
“In fact, only low levels of the HSD17B1 gene and protein (Dassen et al., 2007) or total absence of this enzyme (Utsunomiya et al., 2001) were reported in the endometrium of nonaffected women.”
BackgroundResultInfluentialConcurrent estrogen action was essential for maximal progestin effect in oral contraceptives
Bono, Y., Kyo, S., Kiyono, T., Mizumoto, Y., Nakamura, M., Maida, Y., Takakura, M., & Fujiwara, H. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.005 · Cited by 16
Microanatomy and function of the eutopic endometrium in women with endometriosis
Al‐Jefout, M., Tokushige, N., Hey‐Cunningham, A. J., Manconi, F., Ng, C. H. M., Schulke, L., Berbic, M., Markham, R., & Is, F. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.4.1.61 · Cited by 16
m6A methyltransferase METTL3 inhibits endometriosis by regulating alternative splicing of MIR17HG
Li, Q., Li, Y., Zhang, F., Liu, J., Jiang, M., Chen, Y., & Ren, C. (2023) · Reproduction · doi:10.1530/rep-22-0102 · Cited by 15
Activin A Stimulates Aromatase via the ALK4-Smad Pathway in Endometriosis
Zheng, J., Qu, J., Lu, P., Hou, Z., Cui, Y., Mao, Y., Qi, X., Ji, H., & Liu, J. (2016) · BioMed Research International · doi:10.1155/2016/5791510 · Cited by 15
“Numerous reports have confirmed the expression of P450arom in the endometrium at the mRNA transcriptional level [31, 32, 34, 37], at the protein translational level [30, 33, 35], and in enzymatic activity [35, 36].”
BackgroundStarčević, Š., Turk, S., Brus, B., Cesar, J., Rižner, T. L., & Gobec, S. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.08.013 · Cited by 15
Beranič, N., & Rižner, T. L. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.07.004 · Cited by 14
Medical treatment improves social behavior in a primate endometriosis model ( C allithrix jacchus)
Arnold, C., & Einspanier, A. (2013) · Journal of Medical Primatology · doi:10.1111/jmp.12042 · Cited by 13
SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis
Piccinato, C. D. A., Malvezzi, H., Gibson, D. A., & Saunders, P. T. K. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0297 · Cited by 15
In vivo mouse model for analysis of hydroxysteroid (17β) dehydrogenase 1 inhibitors
Lamminen, T., Saloniemi, T., Huhtinen, K., Koskimies, P., Messinger, J., Husen, B., Thole, H., & POUTANEN, M. H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.034 · Cited by 13
Self-citationde Graaff, A. A., Delvoux, B., de Vijver, K. K. V., Kyama, C. M., D’Hooghe, T., Dunselman, G. A. J., & Romano, A. (2012) · Human Reproduction · doi:10.1093/humrep/des124 · Cited by 13
“RNA of the lesions (the presence of tissue other than the endometrium), the expression of the HSD17B4 gene, which was previously shown to be equal in the endometrium inside the uterus and in the endometriotic tissue (Dassen et al., 2007), was assessed.”
Self-citationYu, Y., Zhu, Y., Gao, M., Wang, Y., Li, S., & Gou, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1624569 · Cited by 12
Cheng, Y.-H., Huang, C., Lien, H.-T., Hsiao, Y.-Y., Weng, P.-L., Chang, Y.-C., Cheng, J., & Lan, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073873 · Cited by 12
Fischer, L., Deppert, W. R., Pfeifer, D., Stanzel, S. F., Weimer, M. S., Hanjalic-Beck, A., Stein, A., Straßer, M., Zahradnik, H. P., & Schaefer, W. R. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.02.016 · Cited by 12
Kamergorodsky, G., Invitti, A. L., D’Amora, P., Parreira, R. M., Kopelman, A., Bonetti, T. C., Girão, M. J. B. C., & Schor, E. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110743 · Cited by 12
Beranič, N., & Rižner, T. L. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.10.028 · Cited by 12
HSD17B1 expression induces inflammation-aided rupture of mammary gland myoepithelium
Järvensivu, P., Heinosalo, T., Hakkarainen, J., Kronqvist, P., Saarinen, N., & POUTANEN, M. H. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0476 · Cited by 12
Wu, C.-H., Yang, J.-G., Chang, Y., Hsu, C., & Kuo, P. (2013) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2013.10.006 · Cited by 11
“Gene transcripts for types 1 and 7 HSD17B and estrogen sulfatase were found to be overexpressed in endometriotic tissues when compared with normal endometrium [43].”
BackgroundEstrogen Biosynthesis and Its Regulation in Endometriosis
Qi, Q.-M., Guo, S., & Liu, X. (2017) · Reproductive and Developmental Medicine · doi:10.4103/2096-2924.210698 · Cited by 11
In the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis
Philibert, P., Déjardin, S., Pirot, N., Pruvost, A., Nguyen, A. L., Bernex, F., Poulat, F., & Boizet‐Bonhoure, B. (2021) · Molecular Human Reproduction · doi:10.1093/molehr/gaab029 · Cited by 11
Gibson, D. A., Foster, P. A., Simitsidellis, I., Critchley, H. O. D., Kelepouri, O., Collins, F., & Saunders, P. T. K. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0037 · Cited by 10
Colgrave, E. M., Keast, J. R., Healey, M., Rogers, P. A. W., Girling, J. E., & Holdsworth‐Carson, S. J. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.103409 · Cited by 10
Up-regulation of DNA2 results in cell proliferation and migration in endometriosis
Wang, X., Zeng, W., Xu, S., Nie, J., Huang, L., Lai, Y., & Yu, Y. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-021-09983-z · Cited by 9
Importance of genital endometriosis in pathogenesis of infertility
Yarmolinskaya, M. I., & Denisova, V. M. (2013) · Journal of obstetrics and women s diseases · doi:10.17816/jowd62667-77 · Cited by 8
Role of estrogen and estrogen-related factors in endometriosis
Mori, T., & Kitawaki, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820661-4.00022-4 · Cited by 8
Metadata
- Authors
- Dassen, H., Punyadeera, C., Kamps, R., Delvoux, B., Van Langendonckt, A., Donnez, J., Husen, B., Thole, H., Dunselman, G., & Groothuis, P.
- Affiliations
- Maastricht University Medical Centre (NL)
- UCLouvain (BE)
- Solvay (Germany) (DE)
- Corresponding author
- Dunselman, G.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-18
- Volume
- 22
- Issue
- 12
- Pages
- 3148-3158
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2117221582
- Cited by
- 141
- References
- 68
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 6 · 2018: 10 · 2017: 4 · 2016: 7 · 2015: 13 · 2014: 7 · 2013: 7 · 2012: 13
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- endometriosis, deep infiltrating endometriosis, eutopic endometrium, ectopic endometrium, estradiol, aromatase, 17β-hydroxysteroid dehydrogenase, estrogen sulfotransferase, steroid sulfatase, progesterone regulation, explant culture
- MeSH terms
- Adult, Animals, Antibody Specificity, Aromatase, Endometriosis, Endometrium, Estrogens, Female, Humans, Immunohistochemistry, Menstrual Cycle, Middle Aged, Rabbits, RNA, Messenger, 17-Hydroxysteroid Dehydrogenases, Sulfotransferases, Gene Expression Regulation, Enzymologic, Steryl-Sulfatase, Tissue Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.